1 539 121 COMPLEMENTARY THERAPIES IN PARKINSON DISEASE: A REVIEW OF ACUPUNCTURE, TAI CHI, QI GONG, YOGA, AND CANNABIS. PARKINSON DISEASE (PD) IS A PROGRESSIVE NEURODEGENERATIVE CONDITION CHARACTERIZED BY BRADYKINESIA, RIGIDITY, RESTING TREMOR, AND POSTURAL INSTABILITY. NON-MOTOR SYMPTOMS, INCLUDING PAIN, FATIGUE, INSOMNIA, ANXIETY, AND DEPRESSION TO NAME A FEW, ARE INCREASINGLY RECOGNIZED AND OFTEN JUST AS DISABLING AT MOTOR SYMPTOMS. THE MAINSTAY OF TREATMENT IS DOPAMINE REPLACEMENT; HOWEVER, THE BENEFICIAL EFFECTS TEND TO WANE OVER TIME WITH DISEASE PROGRESSION, AND PATIENTS OFTEN EXPERIENCE MOTOR FLUCTUATIONS AND MEDICATION SIDE EFFECTS. THE LACK OF A DISEASE-MODIFYING INTERVENTION AND THE SHORTCOMINGS OF TRADITIONAL SYMPTOMATIC MEDICATIONS HAVE LED MANY PATIENTS TO PURSUE COMPLEMENTARY THERAPIES TO ALLEVIATE MOTOR AND NON-MOTOR SYMPTOMS ASSOCIATED WITH PD. THE TERM COMPLEMENTARY IMPLIES THAT THE THERAPY IS USED ALONG WITH CONVENTIONAL MEDICINE AND MAY INCLUDE SUPPLEMENTS, MANIPULATIVE TREATMENTS (CHIROPRACTIC, MASSAGE), EXERCISE-BASED PROGRAMS, AND MIND-BODY PRACTICES. AS THESE PRACTICES BECOME MORE WIDESPREAD IN WESTERN MEDICINE, THERE IS A GROWING INTEREST IN EVALUATING THEIR EFFECTS ON A NUMBER OF MEDICAL CONDITIONS, PD INCLUDED. IN THIS REVIEW, WE PROVIDE AN UPDATE ON CLINICAL TRIALS THAT HAVE EVALUATED THE EFFECTIVENESS OF COMPLEMENTARY TREATMENTS FOR PATIENTS WITH PD, SPECIFICALLY FOCUSING ON ACUPUNCTURE, TAI CHI, QI GONG, YOGA, AND CANNABIS. 2020 2 451 29 CHANGES IN FATIGUE, AUTONOMIC FUNCTIONS, AND BLOOD BIOMARKERS DUE TO SITTING ISOMETRIC YOGA IN PATIENTS WITH CHRONIC FATIGUE SYNDROME. BACKGROUND: IN A PREVIOUS RANDOMIZED CONTROLLED TRIAL, WE FOUND THAT SITTING ISOMETRIC YOGA IMPROVES FATIGUE IN PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) WHO ARE RESISTANT TO CONVENTIONAL THERAPY. THE AIM OF THIS STUDY WAS TO INVESTIGATE POSSIBLE MECHANISMS BEHIND THIS FINDING, FOCUSING ON THE SHORT-TERM FATIGUE-RELIEVING EFFECT, BY COMPARING AUTONOMIC NERVOUS FUNCTION AND BLOOD BIOMARKERS BEFORE AND AFTER A SESSION OF ISOMETRIC YOGA. METHODS: FIFTEEN PATIENTS WITH CFS WHO REMAINED SYMPTOMATIC DESPITE AT LEAST 6 MONTHS OF CONVENTIONAL THERAPY PRACTICED SITTING ISOMETRIC YOGA (BIWEEKLY 20 MIN PRACTICE WITH A YOGA INSTRUCTOR AND DAILY HOME PRACTICE) FOR EIGHT WEEKS. ACUTE EFFECTS OF SITTING ISOMETRIC YOGA ON FATIGUE, AUTONOMIC FUNCTION, AND BLOOD BIOMARKERS WERE INVESTIGATED AFTER THE FINAL SESSION WITH AN INSTRUCTOR. THE EFFECT OF A SINGLE SESSION OF SITTING ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY THE PROFILE OF MOOD STATUS (POMS) QUESTIONNAIRE IMMEDIATELY BEFORE AND AFTER THE SESSION. AUTONOMIC NERVOUS FUNCTION (HEART RATE (HR) VARIABILITY) AND BLOOD BIOMARKERS (CORTISOL, DHEA-S, TNF-ALPHA, IL-6, IFN-GAMMA, IFN-ALPHA, PROLACTIN, CARNITINE, TGF-BETA1, BDNF, MHPG, AND HVA) WERE COMPARED BEFORE AND AFTER THE SESSION. RESULTS: SITTING ISOMETRIC YOGA SIGNIFICANTLY REDUCED THE POMS FATIGUE SCORE (P < 0.01) AND INCREASED THE VIGOR SCORE (P < 0.01). IT ALSO REDUCED HR (P < 0.05) AND INCREASED THE HIGH FREQUENCY POWER (P < 0.05) OF HR VARIABILITY. SITTING ISOMETRIC YOGA INCREASED SERUM LEVELS OF DHEA-S (P < 0.05), REDUCED LEVELS OF CORTISOL (P < 0.05) AND TNF-ALPHA (P < 0.05), AND HAD A TENDENCY TO REDUCE SERUM LEVELS OF PROLACTIN (P < 0.1). DECREASES IN FATIGUE SCORES CORRELATED WITH CHANGES IN PLASMA LEVELS OF TGF-BETA1 AND BDNF. IN CONTRAST, INCREASED VIGOR POSITIVELY CORRELATED WITH HVA. CONCLUSIONS: A SINGLE SESSION OF SITTING ISOMETRIC YOGA REDUCED FATIGUE AND INCREASED VIGOR IN PATIENTS WITH CFS. YOGA ALSO INCREASED VAGAL NERVE FUNCTION AND CHANGED BLOOD BIOMARKERS IN A PATTERN THAT SUGGESTED ANTI-STRESS AND ANTI-INFLAMMATORY EFFECTS. THESE CHANGES APPEAR TO BE RELATED TO THE SHORT-TERM FATIGUE-RELIEVING EFFECT OF SITTING ISOMETRIC YOGA IN PATIENTS WITH CFS. FURTHERMORE, DOPAMINERGIC NERVOUS SYSTEM ACTIVATION MIGHT ACCOUNT FOR SITTING ISOMETRIC YOGA-INDUCED INCREASES IN ENERGY IN THIS PATIENT POPULATION. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000009646. REGISTERED DEC 27, 2012. 2018 3 2254 31 THE ORIGIN AND CLINICAL RELEVANCE OF YOGA NIDRA. YOGA NIDRA, ALSO KNOWN AS 'YOGIC SLEEP', IS A SIMPLIFIED FORM OF AN ANCIENT TANTRIC RELAXATION TECHNIQUE. THE MOST GENERAL DESCRIPTION OF THE PRACTICE IS THAT IT COMBINES GUIDED MENTAL IMAGERY WITH A SPECIFIC YOGA POSTURE CALLED SHAVASANA (OR "CORPSE POSE"). THE GOAL OF YOGA NIDRA IS TO PROMOTE A PROFOUND STATE OF RELAXATION, WHICH DIFFERS FROM SLEEP INASMUCH AS THERE IS STILL AN AWARENESS OF ONE'S SURROUNDINGS. WHILE SEVERAL COMPONENTS OF THE PRACTICE HAVE BEEN KNOWN SINCE ANCIENT TIMES, IT WAS NOT UNTIL THE 1960S THAT AN UPDATED AND SYSTEMATIZED SYSTEM OF PRACTICE WAS INTRODUCED TO THE PUBLIC THROUGH THE WRITINGS OF SWAMI SATYANANDA SARASWATI. UNLIKE OTHER SCHOOLS OF YOGA, WHICH EMPHASIZE CONCENTRATION OR CONTEMPLATION, YOGA NIDRA'S GOAL IS COMPLETE RELAXATION. AS SUCH, ITS ADVOCATES CLAIM THAT IT IS SUITABLE FOR ALL INDIVIDUALS, FROM BEGINNERS TO ADVANCED PRACTITIONERS OF YOGA. THE CALM INNER STILLNESS INDUCED BY YOGA NIDRA IS CLAIMED BY PRACTITIONERS TO BE AN EFFECTIVE STRESS MANAGEMENT TOOL AS WELL AS A MEANS FOR ATTAINING GREATER RECEPTIVITY TO PERSONAL RESOLUTIONS. THESE RESOLUTIONS CAN RANGE FROM THE GOAL OF ACHIEVING SELF-TRANSFORMATION, ENHANCING CREATIVITY, OR IMPROVING ONE'S LEARNING ABILITY. ADDITIONALLY, YOGA NIDRA IS CLAIMED TO PROMOTE BENEFICIAL CHANGES IN PHYSIOLOGICAL AND MENTAL HEALTH. THE FOLLOWING NARRATIVE REVIEW SUMMARIZES THE BASIC STEPS USED TO ACHIEVE THE FINAL STATE OF YOGA NIDRA RELAXATION AS WELL AS SOME RECENT EXPERIMENTAL FINDINGS REGARDING ITS PHYSIOLOGICAL AND PSYCHOLOGICAL EFFECTS. STANDARD RESEARCH DATABASES WERE SEARCHED FOR RELEVANT ARTICLES. CLINICAL STUDIES HAVE SHOWN THAT YOGA NIDRA MEDITATION IS ASSOCIATED WITH POSITIVE PHYSIOLOGICAL CHANGES, INCLUDING IMPROVEMENTS IN SEVERAL HEMATOLOGICAL VARIABLES, RED BLOOD CELL COUNTS, BLOOD GLUCOSE LEVELS, AND HORMONAL STATUS. TWO NEUROIMAGING STUDIES HAVE SHOWN THAT YOGA NIDRA PRODUCES CHANGES IN ENDOGENOUS DOPAMINE RELEASE AND CEREBRAL BLOOD FLOW, A FURTHER CONFIRMATION THAT ITS EFFECTS ON THE CNS ARE OBJECTIVELY MEASURABLE. THE PRACTICE HAS ALSO BEEN SHOWN TO REDUCE PSYCHOMETRICALLY MEASURED INDICES OF MILD DEPRESSION AND ANXIETY, ALTHOUGH THESE BENEFITS WERE NOT SHOWN IN AN EXPERIMENTAL STUDY TO EXTEND TO SEVERE DEPRESSION OR SEVERE ANXIETY. 2022 4 702 43 EFFECT OF HOME-BASED TAI CHI, YOGA OR CONVENTIONAL BALANCE EXERCISE ON FUNCTIONAL BALANCE AND MOBILITY AMONG PERSONS WITH IDIOPATHIC PARKINSON'S DISEASE: AN EXPERIMENTAL STUDY. BACKGROUND: INDIVIDUALS WITH PARKINSON'S DISEASE (PD) INVARIABLY EXPERIENCE FUNCTIONAL DECLINE IN A NUMBER OF MOTOR AND NON-MOTOR DOMAINS AFFECTING POSTURE, BALANCE AND GAIT. NUMEROUS CLINICAL STUDIES HAVE EXAMINED EFFECTS OF VARIOUS TYPES OF EXERCISE ON MOTOR AND NON-MOTOR PROBLEMS. BUT STILL MUCH GAP REMAINS IN OUR UNDERSTANDING OF VARIOUS THERAPIES AND THEIR EFFECT ON DELAYING OR SLOWING THE DOPAMINE NEURON DEGENERATION. RECENTLY, TAI CHI AND YOGA BOTH HAVE GAINED POPULARITY AS COMPLEMENTARY THERAPIES, SINCE BOTH HAVE COMPONENTS FOR MIND AND BODY CONTROL. OBJECTIVE: THE AIM OF THIS STUDY WAS TO DETERMINE WHETHER EIGHT WEEKS OF HOME-BASED TAI CHI OR YOGA WAS MORE EFFECTIVE THAN REGULAR BALANCE EXERCISES ON FUNCTIONAL BALANCE AND MOBILITY. METHODS: TWENTY-SEVEN INDIVIDUALS WITH IDIOPATHIC PD (MODIFIED HOEHN AND YAHR STAGES 2.5-3) WERE RANDOMLY ASSIGNED TO EITHER TAI CHI, YOGA OR CONVENTIONAL EXERCISE GROUP. ALL THE PARTICIPANTS WERE EVALUATED FOR FUNCTIONAL BALANCE AND MOBILITY USING BERG BALANCE SCALE, TIMED 10 M WALK TEST AND TIMED UP AND GO TEST BEFORE AND AFTER EIGHT WEEKS OF TRAINING. RESULTS: THE RESULTS WERE ANALYZED USING TWO-WAY MIXED ANOVA WHICH SHOWED THAT THERE WAS A SIGNIFICANT MAIN EFFECT FOR TIME AS F (1, 24) = 74.18, P = 0 . 000 , ETA P 2 = 0 . 76 FOR OVERALL BALANCE IN BERG BALANCE SCALE. THERE WAS ALSO SIGNIFICANT MAIN EFFECT OF TIME ON MOBILITY OVERALL AS F(1, 24) = 77 . 78 , P = 0 . 000 , ETA P 2 = 0 . 76 IN TIMED UP AND GO TEST AND F(1, 24) = 48 . 24 , P = 0 . 000 , ETA P 2 = 0 . 67 FOR 10 M WALK TEST. THERE WAS A SIGNIFICANT INTERACTION EFFECT FOR TIME X GROUP WITH F(2, 24) = 8 . 67 , P = 0 . 001 , ETA P 2 = 0 . 420 FOR BALANCE. WITH RESPECT TO MOBILITY, THE VALUES F(2, 24) = 5 . 92 , P = 0 . 008 , ETA P 2 = 0 . 330 IN TIMED UP AND GO TEST AND F(2, 24) = 10 . 40 , P = 0 . 001 , ETA P 2 = 0 . 464 IN 10 M WALK TEST SHOWED A SIGNIFICANT INTERACTION. BUT THERE WAS NO SIGNIFICANT MAIN EFFECT BETWEEN THE GROUPS FOR BOTH BALANCE AND MOBILITY. CONCLUSION: THE FINDINGS OF THIS STUDY SUGGEST THAT TAI CHI AS WELL AS YOGA ARE WELL ADHERED AND ARE ATTRACTIVE OPTIONS FOR A HOME-BASED SETTING. AS ANY FORM OF PHYSICAL ACTIVITY IS CONSIDERED BENEFICIAL FOR INDIVIDUALS WITH PD EITHER TAI CHI, YOGA OR CONVENTIONAL BALANCE EXERCISES COULD BE USED AS THERAPEUTIC INTERVENTION TO OPTIMIZE BALANCE AND MOBILITY. FURTHER STUDIES ARE NECESSARY TO UNDERSTAND THE MIND-BODY BENEFITS OF TAI CHI AND YOGA EITHER AS MULTICOMPONENT PHYSICAL ACTIVITIES OR AS INDIVIDUAL THERAPIES IN VARIOUS STAGES OF PD. 2020 5 1072 34 EFFECTS OF YOGA ON OXIDATIVE STRESS, MOTOR FUNCTION, AND NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE: A PILOT RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO EXAMINE THE FEASIBILITY, ACCEPTABILITY, AND PRELIMINARY EFFECTS OF HATHA YOGA ON OXIDATIVE STRESS, MOTOR FUNCTION, AND NON-MOTOR SYMPTOMS AMONG INDIVIDUALS WITH PARKINSON'S DISEASE (PD). METHODS: THE STUDY HAS A PILOT RANDOMIZED CONTROLLED TRIAL DESIGN WITH TWO ARMS: AN IMMEDIATE TREATMENT GROUP AND A WAIT-LIST CONTROL GROUP. THE YOGA-FOR-PD PROGRAM WAS IMPLEMENTED VIA TWICE WEEKLY 60-MIN GROUP-BASED CLASSES FOR 12 WEEKS. PARTICIPANTS WERE ASSESSED AT BASELINE, 12 WEEKS, AND 6 MONTHS POST-INTERVENTION. OUTCOME MEASURES INCLUDED OXIDATIVE STRESS, MOTOR FUNCTION, PHYSICAL ACTIVITY, COGNITIVE FUNCTION, SLEEP QUALITY, AND QUALITY OF LIFE. DATA ON PROGRAM ACCEPTABILITY AND YOGA ADHERENCE WERE COLLECTED DURING THE INTERVENTION AND AT 6 MONTHS POST-INTERVENTION. RESULTS: PARTICIPANTS (N = 20) HAD A MEAN AGE OF 63 YEARS (SD 8, RANGE 49-75) AND DISEASE DURATION 4.8 YEARS (SD 2.9, RANGE 1-13). ALL PARTICIPANTS HAD MILD-MODERATE DISEASE SEVERITY; 18 (90%) WERE ON DOPAMINERGIC MEDICATIONS. SEVENTEEN PARTICIPANTS (85%) ATTENDED AT LEAST 75% OF THE CLASSES AND 4 (20%) ATTENDED ALL CLASSES. MOST PARTICIPANTS (N = 17) REPORTED THEY "DEFINITELY ENJOYED" THE INTERVENTION PROGRAM. NO ADVERSE EVENTS WERE REPORTED. AT 12 WEEKS, THERE WERE NO MAJOR DIFFERENCES IN BLOOD OXIDATIVE STRESS MARKERS BETWEEN THE TWO GROUPS. MOTOR FUNCTION BASED ON THE UNIFIED PARKINSON'S DISEASE RATING SCALE WAS BETTER IN THE TREATMENT GROUP, BUT THEIR SCORES ON SLEEP AND OUTLOOK IN PARKINSON'S DISEASE QUALITY OF LIFE (PDQUALIF) SCALE AND THE PHYSICAL ACTIVITY LEVELS BASED ON THE LONGITUDINAL AGING STUDY AMSTERDAM PHYSICAL ACTIVITY QUESTIONNAIRE WERE WORSE THAN THOSE OF THE CONTROL GROUP. IN WITHIN-GROUP COMPARISONS, MOTOR FUNCTION, COGNITIVE FUNCTION, AND CATALASE IMPROVED BUT THREE PDQUALIF DOMAINS (SOCIAL AND ROLE FUNCTION, SLEEP, AND OUTLOOK) AND PHYSICAL ACTIVITY LEVEL WORSENED BY THE END OF THE YOGA INTERVENTION PROGRAM COMPARED TO BASELINE. THE RESPONSE RATE FOR THE 6-MONTH FOLLOW-UP SURVEY WAS 74% (N = 14) WITH SIX PARTICIPANTS (43%) WHO SIGNED UP FOR A YOGA CLASS AND FOUR (29%) WHO PRACTICED IT INDEPENDENTLY. HEALTH PROBLEMS WERE THE MAIN BARRIER TO YOGA PRACTICE. CONCLUSION: YOGA IS FEASIBLE AND ACCEPTABLE AND MAY SERVE AS A COMPLEMENTARY METHOD FOR IMPROVING MOTOR FUNCTION IN PD. FURTHER RESEARCH USING A LARGER SAMPLE SIZE IS NEEDED TO DETERMINE ITS IMPACT ON OXIDATIVE STRESS AND NON-MOTOR SYMPTOMS. TRIAL REGISTRATION: CLINICALTRIALS.GOV REGISTRATION NUMBER: NCT02509610031. 2018 6 550 22 CONTROLLED PILOT STUDY OF THE EFFECTS OF POWER YOGA IN PARKINSON'S DISEASE. OBJECTIVES: TO EVALUATE THE EFFECTS OF A SPECIALLY DESIGNED POWER YOGA PROGRAM (YOGA) ON BRADYKINESIA, RIGIDITY, MUSCULAR PERFORMANCE AND QUALITY OF LIFE IN OLDER PATIENTS WITH PD. DESIGN: RANDOMIZED CONTROLLED TRIAL. SETTING: UNIVERSITY LABORATORY, US. INTERVENTION: TWENTY-SIX PATIENTS WITH MILD TO MODERATE PD WERE RANDOMLY ASSIGNED TO A YOGA OR CONTROL GROUP (CON). THE YOGA PROGRAM WAS THREE MONTHS, INCORPORATING TWO SESSIONS/WK OF YOGA CLASSES. MAIN OUTCOME MEASURES: UPPER AND LOWER LIMB BRADYKINESIA AND RIGIDITY SCORES FROM THE UNIFIED PARKINSON'S DISEASE RATING SCALE, ONE REPETITION MAXIMUMS (1RM) AND PEAK POWERS ON BICEPS CURL, CHEST PRESS, LEG PRESS, HIP ABDUCTION AND SEATED CALF, AND QUALITY OF LIFE (PDQ-39). RESULTS: THE YOGA GROUP PRODUCED SIGNIFICANT IMPROVEMENT IN BOTH UPPER AND LOWER LIMBS BRADYKINESIA SCORES, RIGIDITY SCORE, 1RM FOR ALL 5 MACHINES AND LEG PRESS POWER (P<.05). SIGNIFICANT IMPROVEMENTS WERE SEEN IN THE PDQ-39 OVERALL SCORE, MOBILITY AND ACTIVITIES OF DAILY LIVING DOMAIN FOR THE YOGA GROUP. CONCLUSION: THE 3-MONTH YOGA PROGRAM SIGNIFICANTLY REDUCED BRADYKINESIA AND RIGIDITY, AND INCREASED MUSCLE STRENGTH AND POWER IN OLDER PATIENTS WITH PD. POWER TRAINING IS AN EFFECTIVE TRAINING MODALITY TO IMPROVE PHYSICAL FUNCTION AND QUALITY OF LIFE FOR PD. 2016 7 2250 32 THE LONGITUDINAL EFFECTS OF SEATED ISOMETRIC YOGA ON BLOOD BIOMARKERS, AUTONOMIC FUNCTIONS, AND PSYCHOLOGICAL PARAMETERS OF PATIENTS WITH CHRONIC FATIGUE SYNDROME: A PILOT STUDY. BACKGROUND: IN A PREVIOUS RANDOMIZED CONTROLLED TRIAL, WE FOUND THAT PRACTICING SEATED ISOMETRIC YOGA REGULARLY FOR 2 MONTHS IMPROVED THE FATIGUE OF PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) WHO ARE RESISTANT TO CONVENTIONAL THERAPY. THE AIM OF THIS PILOT STUDY WAS TO INVESTIGATE THE POSSIBLE MECHANISMS BEHIND THIS FINDING BY COMPARING BLOOD BIOMARKERS, AUTONOMIC NERVOUS FUNCTION, AND PSYCHOLOGICAL INDICES BEFORE VERSUS AFTER AN INTERVENTION PERIOD OF SEATED ISOMETRIC YOGA PRACTICE. METHODS: FIFTEEN PATIENTS WITH CFS WHO DID NOT SHOW SATISFACTORY IMPROVEMENTS AFTER AT LEAST 6 MONTHS OF CONVENTIONAL THERAPY PRACTICED SEATED ISOMETRIC YOGA (BIWEEKLY 20-MIN SESSIONS WITH A YOGA INSTRUCTOR AND DAILY PRACTICE AT HOME) FOR 2 MONTHS. THE LONGITUDINAL EFFECTS OF SEATED ISOMETRIC YOGA ON FATIGUE, BLOOD BIOMARKERS, AUTONOMIC FUNCTION, AND PSYCHOLOGICAL STATE WERE INVESTIGATED BY COMPARING THE FOLLOWING PARAMETERS BEFORE AND AFTER THE INTERVENTION PERIOD: FATIGUE SEVERITY WAS ASSESSED BY THE CHALDER FATIGUE SCALE (FS) SCORE. LEVELS OF THE BLOOD BIOMARKERS CORTISOL, DHEA-S, TNF-ALPHA, IL-6, PROLACTIN, CARNITINE, TGF-BETA1, BDNF, MHPG, HVA, AND ALPHA-MSH WERE MEASURED. THE AUTONOMIC NERVOUS FUNCTIONS ASSESSED WERE HEART RATE (HR) AND HR VARIABILITY. PSYCHOLOGICAL INDICES INCLUDED THE 20-ITEM TORONTO ALEXITHYMIA SCALE (TAS-20) AND THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS). RESULTS: PRACTICING SEATED ISOMETRIC YOGA FOR 2 MONTHS RESULTED IN SIGNIFICANT REDUCTIONS IN THE CHALDER FS (P = 0.002) AND HADS-DEPRESSION (P = 0.02) SCORES. NO SIGNIFICANT CHANGES WERE OBSERVED IN ANY OTHER PARAMETER EVALUATED. THE CHANGE IN CHALDER FS SCORE WAS NOT CORRELATED WITH THE CHANGE IN HADS-DEPRESSION SCORE. HOWEVER, THIS CHANGE WAS POSITIVELY CORRELATED WITH CHANGES IN THE SERUM TNF-ALPHA LEVELS (P = 0.048), THE HIGH FREQUENCY COMPONENT OF HR VARIABILITY (P = 0.042), AND TAS-20 SCORES (P = 0.001). CONCLUSIONS: REGULAR PRACTICE OF SEATED ISOMETRIC YOGA FOR 2 MONTHS REDUCED THE FATIGUE AND DEPRESSIVE SYMPTOM SCORES OF PATIENTS WITH CFS WITHOUT AFFECTING ANY OTHER PARAMETERS WE INVESTIGATED. THIS STUDY FAILED TO IDENTIFY THE MARKERS RESPONSIBLE FOR THE LONGITUDINAL FATIGUE-RELIEVING EFFECT OF SEATED ISOMETRIC YOGA. HOWEVER, CONSIDERING THAT THE REDUCED FATIGUE WAS ASSOCIATED WITH DECREASED SERUM TNF-ALPHA LEVEL AND TAS-20 SCORES, FATIGUE IMPROVEMENT MIGHT BE RELATED TO REDUCED INFLAMMATION AND IMPROVED ALEXITHYMIA IN THESE PATIENTS. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000009646. REGISTERED DEC 27, 2012. 2019 8 2847 29 YOGA, MEDITATION AND MIND-BODY HEALTH: INCREASED BDNF, CORTISOL AWAKENING RESPONSE, AND ALTERED INFLAMMATORY MARKER EXPRESSION AFTER A 3-MONTH YOGA AND MEDITATION RETREAT. THIRTY-EIGHT INDIVIDUALS (MEAN AGE: 34.8 YEARS OLD) PARTICIPATING IN A 3-MONTH YOGA AND MEDITATION RETREAT WERE ASSESSED BEFORE AND AFTER THE INTERVENTION FOR PSYCHOMETRIC MEASURES, BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF), CIRCADIAN SALIVARY CORTISOL LEVELS, AND PRO- AND ANTI-INFLAMMATORY CYTOKINES. PARTICIPATION IN THE RETREAT WAS FOUND TO BE ASSOCIATED WITH DECREASES IN SELF-REPORTED ANXIETY AND DEPRESSION AS WELL AS INCREASES IN MINDFULNESS. AS HYPOTHESIZED, INCREASES IN THE PLASMA LEVELS OF BDNF AND INCREASES IN THE MAGNITUDE OF THE CORTISOL AWAKENING RESPONSE (CAR) WERE ALSO OBSERVED. THE NORMALIZED CHANGE IN BDNF LEVELS WAS INVERSELY CORRELATED WITH BSI-18 ANXIETY SCORES AT BOTH THE PRE-RETREAT (R = 0.40, P < 0.05) AND POST-RETREAT (R = 0.52, P < 0.005) SUCH THAT THOSE WITH GREATER ANXIETY SCORES TENDED TO EXHIBIT SMALLER PRE- TO POST-RETREAT INCREASES IN PLASMA BDNF LEVELS. IN LINE WITH A HYPOTHESIZED DECREASE IN INFLAMMATORY PROCESSES RESULTING FROM THE YOGA AND MEDITATION PRACTICES, WE FOUND THAT THE PLASMA LEVEL OF THE ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 WAS INCREASED AND THE PRO-INFLAMMATORY CYTOKINE INTERLEUKIN-12 WAS REDUCED AFTER THE RETREAT. CONTRARY TO OUR INITIAL HYPOTHESES, PLASMA LEVELS OF OTHER PRO-INFLAMMATORY CYTOKINES, INCLUDING INTERFERON GAMMA (IFN-GAMMA), TUMOR NECROSIS FACTOR (TNF-ALPHA), INTERLEUKIN-1BETA (IL-1BETA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-8 (IL-8) WERE INCREASED AFTER THE RETREAT. GIVEN EVIDENCE FROM PREVIOUS STUDIES OF THE POSITIVE EFFECTS OF MEDITATIVE PRACTICES ON MENTAL FITNESS, AUTONOMIC HOMEOSTASIS AND INFLAMMATORY STATUS, WE HYPOTHESIZE THAT THESE FINDINGS ARE RELATED TO THE MEDITATIVE PRACTICES THROUGHOUT THE RETREAT; HOWEVER, SOME OF THE OBSERVED CHANGES MAY ALSO BE RELATED TO OTHER ASPECTS OF THE RETREAT SUCH AS PHYSICAL EXERCISE-RELATED COMPONENTS OF THE YOGA PRACTICE AND DIET. WE HYPOTHESIZE THAT THE PATTERNS OF CHANGE OBSERVED HERE REFLECT MIND-BODY INTEGRATION AND WELL-BEING. THE INCREASED BDNF LEVELS OBSERVED IS A POTENTIAL MEDIATOR BETWEEN MEDITATIVE PRACTICES AND BRAIN HEALTH, THE INCREASED CAR IS LIKELY A REFLECTION OF INCREASED DYNAMIC PHYSIOLOGICAL AROUSAL, AND THE RELATIONSHIP OF THE DUAL ENHANCEMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINE CHANGES TO HEALTHY IMMUNOLOGIC FUNCTIONING IS DISCUSSED. 2017 9 593 27 DEVELOPMENT AND EVALUATION OF A YOGA INTERVENTION PROGRAM FOR PARKINSON'S DISEASE. PRELIMINARY RESEARCH INDICATES THAT YOGA COULD BE A VALUABLE TOOL FOR PEOPLE SUFFERING FROM PARKINSON'S DISEASE (PD). HOWEVER, LITTLE HAS BEEN PUBLISHED ABOUT THE PROCESS BY WHICH THE YOGA INTERVENTIONS WERE DESIGNED AND EVALUATED. THIS STUDY ELABORATES ON THE PROCESS OF DEVELOPING AND TESTING A BI-WEEKLY, 12-WEEK YOGA PROGRAM TO DETERMINE ITS SAFETY AND FEASIBILITY FOR PEOPLE WITH PD. THE LEAD YOGA TEACHER USED INPUT FROM A FOCUSED LITERATURE REVIEW TO DESIGN AN INITIAL DRAFT OF THE INTERVENTION PROGRAM. THIS DRAFT WAS REVIEWED BY A GROUP OF YOGA EXPERTS ( N = 6) TO DEVELOP THE FINAL INTERVENTION PROGRAM. THIS 12-WEEK INTERVENTION WAS IMPLEMENTED IN 19 PARTICIPANTS WITH PD (MEAN AGE 63 +/- 8, RANGE 49-75) VIA TWICE-WEEKLY YOGA CLASSES. THROUGH THIS COMPREHENSIVE DEVELOPMENT PROCESS, A SERIES OF 24 INDIVIDUAL 1-HOUR YOGA SEQUENCES WAS CREATED. THESE SEQUENCES INCLUDED YOGA POSTURES (ASANA), BREATHING TECHNIQUES (PRANAYAMA), AND MINDFULNESS MEDITATION PRINCIPLES SPECIFICALLY CHOSEN TO ADDRESS CONCERNS UNIQUE TO THE PD POPULATION. THE FEASIBILITY OF THE PROGRAM WAS SUPPORTED WITH EXCELLENT ATTENDANCE: 90% OF PARTICIPANTS ATTENDED > 75% OF THE CLASSES, WITH FOUR PARTICIPANTS ATTENDING 100%. NO ADVERSE EVENTS WERE REPORTED. THIS DEVELOPMENT PROCESS PRODUCED A SAFE AND ENJOYABLE YOGA PROGRAM SPECIFIC FOR THE NEEDS OF PEOPLE WITH PD. HOWEVER, THIS METHODOLOGY COULD SERVE AS A TEMPLATE FOR FUTURE STUDIES ON HOW TO DEVELOP SAFE AND EFFECTIVE YOGA INTERVENTIONS FOR OTHER POPULATIONS. 2018 10 456 30 CHANGES IN NONMOTOR SYMPTOMS FOLLOWING AN 8-WEEK YOGA INTERVENTION FOR PEOPLE WITH PARKINSON'S DISEASE. PARKINSON'S DISEASE (PD) IS A NEURODEGENERATIVE DISORDER MARKED BY PROGRESSIVE DEGENERATIVE MOTOR SYMPTOMS (E.G., TREMORS, IMPAIRED BALANCE AND GAIT) AND NONMOTOR SYMPTOMS (E.G., FATIGUE, SLEEP DISTURBANCES, PAIN) THAT CAN NEGATIVELY INFLUENCE HEALTH-RELATED QUALITY OF LIFE (HRQOL). PREVIOUS STUDIES HAVE SHOWN THAT YOGA FOR INDIVIDUALS WITH PD IMPROVES BALANCE, STRENGTH, AND MOBILITY. HOWEVER, LITTLE RESEARCH HAS BEEN CONDUCTED TO DETERMINE THE EFFECT OF YOGA ON NONMOTOR SYMPTOMS OF PD. THE PURPOSE OF THIS STUDY WAS TO EXAMINE CHANGES IN NONMOTOR SYMPTOMS AMONG INDIVIDUALS WITH PD FOLLOWING AN 8-WEEK YOGA INTERVENTION. DATA USED FOR ANALYSES WERE PART OF A LARGER STUDY THAT RESEARCHED IMPROVEMENTS IN MOTOR FUNCTION FOR INDIVIDUALS WITH PD. PARTICIPANTS (N = 27) WERE RANDOMLY ASSIGNED TO EXPERIMENTAL (N = 15) AND CONTROL (N = 12) GROUPS AND COMPLETED PRE- AND POSTINTERVENTION QUANTITATIVE MEASURES. WITHIN-GROUP IMPROVEMENTS WERE STATISTICALLY SIGNIFICANT FOR FATIGUE MEASURED BY THE PARKINSON'S FATIGUE SCALE, BALANCE CONFIDENCE MEASURED BY THE ACTIVITIES BALANCE CONFIDENCE SCALE, THE BELIEF IN ONE'S ABILITY TO MANAGE FALLS MEASURED BY THE FALLS MANAGEMENT SCALE, ACTIVITY CONSTRAINTS MEASURED BY THE ACTIVITIES CONSTRAINT QUESTIONNAIRE, AND PD-SPECIFIC QUALITY OF LIFE MEASURED BY THE PARKINSON'S DISEASE QUESTIONNAIRE-8. ACROSS-GROUP CHANGES WERE STATISTICALLY SIGNIFICANT FOR ACTIVITY CONSTRAINTS. FINDINGS INDICATE YOGA MAY BE AN EFFICACIOUS INTERVENTION FOR IMPROVING NONMOTOR SYMPTOMS AS WELL AS HRQOL FOR INDIVIDUALS WITH PD. 2019 11 1276 27 FUNCTIONAL IMPROVEMENTS IN PARKINSON'S DISEASE FOLLOWING A RANDOMIZED TRIAL OF YOGA. INDIVIDUALS WITH PARKINSON'S DISEASE (PD) EXPERIENCE SIGNIFICANT LIMITATIONS IN MOTOR FUNCTION, FUNCTIONAL GAIT, POSTURAL STABILITY, AND BALANCE. THESE LIMITATIONS OFTEN LEAD TO HIGHER INCIDENCES OF FALLS, WHICH HAVE SIGNIFICANT COMPLICATIONS FOR INDIVIDUALS WITH PD. YOGA MAY IMPROVE THESE FUNCTIONAL DEFICITS IN INDIVIDUALS WITH PD. THE OBJECTIVE OF THIS STUDY WAS TO DETERMINE CHANGES IN MOTOR FUNCTION, FUNCTIONAL GAIT, POSTURAL STABILITY, AND BALANCE CONTROL FOR COMMUNITY DWELLING INDIVIDUALS WITH PD. THIS RANDOMIZED, WAIT-LIST CONTROLLED PILOT STUDY EXAMINED THE INFLUENCE OF AN 8-WEEK YOGA INTERVENTION FOR PEOPLE WITH PD WHO MET THE FOLLOWING INCLUSION CRITERIA: ENDORSING A FEAR OF FALLING, BEING ABLE TO SPEAK ENGLISH, SCORING 4/6 ON THE MINIMENTAL STATE EXAM, AND BEING WILLING TO ATTEND THE INTERVENTION TWICE WEEKLY FOR 8-WEEKS. PARTICIPANTS IN THE YOGA GROUP (N=15) EXPERIENCED IMPROVEMENTS IN MOTOR FUNCTION, POSTURAL STABILITY, FUNCTIONAL GAIT, AND FREEZING GAIT, AS WELL AS REDUCTIONS IN FALL RISK. PARTICIPANTS IN THE WAIT-LIST CONTROL (N=12) ALSO SIGNIFICANTLY IMPROVED IN POSTURAL STABILITY, ALTHOUGH THEIR FALL RISK WAS NOT REDUCED. INDIVIDUALS IN THE YOGA GROUP SIGNIFICANTLY REDUCED THEIR FALL RISK. AN 8-WEEK YOGA INTERVENTION MAY REDUCE FALL RISK AND IMPROVE POSTURAL STABILITY, AND FUNCTIONAL AND FREEZING GAIT IN INDIVIDUALS WITH PD. THIS CLINICAL TRIAL IS REGISTERED AS PROTOCOL RECORD PRO00041068 IN CLINICALTRIALS.GOV. 2018 12 2277 25 THE ROLES OF EXERCISE AND YOGA IN AMELIORATING DEPRESSION AS A RISK FACTOR FOR COGNITIVE DECLINE. CURRENTLY, THERE ARE NO EFFECTIVE PHARMACEUTICAL TREATMENTS TO REDUCE COGNITIVE DECLINE OR PREVENT DEMENTIA. AT THE SAME TIME, THE GLOBAL POPULATION IS AGING, AND RATES OF DEMENTIA AND MILD COGNITIVE IMPAIRMENT (MCI) ARE ON THE RISE. AS SUCH, THERE IS AN INCREASING INTEREST IN COMPLEMENTARY AND ALTERNATIVE INTERVENTIONS TO TREAT OR REDUCE THE RISK OF COGNITIVE DECLINE. DEPRESSION IS ONE POTENTIALLY MODIFIABLE RISK FACTOR FOR COGNITIVE DECLINE AND DEMENTIA. NOTABLY, EXERCISE AND YOGA ARE TWO INTERVENTIONS KNOWN TO BOTH REDUCE SYMPTOMS OF DEPRESSION AND IMPROVE COGNITIVE FUNCTION. THE CURRENT REVIEW DISCUSSES THE EFFICACY OF EXERCISE AND YOGA TO AMELIORATE DEPRESSION AND THEREBY REDUCE THE RISK OF COGNITIVE DECLINE AND POTENTIALLY PREVENT DEMENTIA. POTENTIAL MECHANISMS OF CHANGE, TREATMENT IMPLICATIONS, AND FUTURE DIRECTIONS ARE DISCUSSED. 2016 13 683 37 EFFECT OF AN 8-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON PSYCHO-NEURO-IMMUNE AXIS, DISEASE ACTIVITY, AND PERCEIVED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. VARIOUS EXTERNAL STRESSORS AND ENVIRONMENTAL CHALLENGES LEAD TO THE PROVOCATION OF THE IMMUNE SYSTEM IN AUTOIMMUNE DISEASES LIKE RHEUMATOID ARTHRITIS (RA). THE INAPPROPRIATE IMMUNE RESPONSE FURTHER TRIGGERS THE CASCADE OF INFLAMMATORY CHANGES RESULTING IN PRECIPITATION OF SYMPTOMS AND HAMPERS QUALITY OF LIFE (QOL). THE UNDERLYING PSYCHO-SOMATIC COMPONENT OF THE DISEASE REQUIRES A HOLISTIC APPROACH TO ITS TREATMENT DIMENSION RATHER THAN THE USE OF PHARMACOTHERAPY. THE APPLICABILITY OF MIND-BODY INTERVENTIONS HAS BECOME ESSENTIAL IN TODAY'S FAST-PACED LIFE. YOGA, A MIND-BODY TECHNIQUE, ALTERS THE MIND'S CAPACITY TO FACILITATE SYSTEMIC FUNCTIONING AT MULTIPLE ORGAN SYSTEM LEVELS. HENCE, WE CONDUCTED THIS STUDY TO EVALUATE THE IMPACT OF 8 WEEKS OF A YOGA-BASED LIFESTYLE INTERVENTION (YBLI) ON PSYCHO-NEURO-IMMUNE MARKERS, GENE EXPRESSION PATTERNS, AND QOL IN RA PATIENTS ON ROUTINE MEDICAL THERAPY. A TOTAL OF 66 PATIENTS WERE RANDOMIZED INTO TWO GROUPS: YOGA GROUP OR NON-YOGA GROUP AND WERE ASSESSED FOR A PANEL OF INFLAMMATORY CYTOKINES (IL-6, IL-17A, TNF-ALPHA, AND TGF-BETA), MIND-BODY COMMUNICATIVE MARKERS (BDNF, DHEAS, BETA-ENDORPHIN, AND SIRTUIN) AND TRANSCRIPT LEVELS OF VARIOUS GENES (IL-6, TNF-ALPHA, NFKB1, TGF-BETA, AND CTLA4). WE ASSESSED DISEASE ACTIVITY AND QOL USING THE DAS28-ESR AND WHOQOL-BREF QUESTIONNAIRE, RESPECTIVELY. YOGA GROUP OBSERVED SIGNIFICANT IMPROVEMENTS IN THE LEVELS OF MARKERS, WHICH INFLUENCED THE PSYCHO-NEURO-IMMUNE AXIS (P < 0.001) WITH AN ESTIMATED EFFECT SIZE FROM SMALL TO MEDIUM RANGE. IN THE YOGA GROUP, THERE WAS A SIGNIFICANT REDUCTION IN DAS28-ESR (P < 0.001) AND IMPROVEMENT SEEN IN THE PHYSICAL HEALTH, PSYCHOLOGICAL, SOCIAL RELATIONSHIPS DOMAINS (P < 0.001) OF QOL, EXCEPT ENVIRONMENTAL (P > 0.05). THE YOGA GROUP SHOWED DOWNREGULATION OF IL-6, TNF-ALPHA, AND CTLA4 AND UPREGULATION OF TGF-BETA. THESE RESULTS SUGGEST THAT A DECREASE IN DISEASE ACTIVITY AFTER YOGA PRACTICE IS ASSOCIATED WITH A SIGNIFICANT REDUCTION IN INFLAMMATORY CYTOKINES, THE ELEVATION OF MIND-BODY COMMUNICATIVE MARKERS, AND NORMALIZATION OF VARIOUS TRANSCRIPT LEVELS, WHICH IMPROVED QOL. THUS THE ADOPTION OF YBLI IMPROVES CLINICAL OUTCOME IN RA, AND DECREASES SYSTEMIC INFLAMMATION BY ITS BENEFICIAL EFFECTS ON PSYCHO-NEURO-IMMUNE AXIS AND NORMALIZATION OF DYSREGULATED TRANSCRIPTS. THUS YBLI MAY BE USED FOR RA PATIENTS AS AN ADJUNCTIVE THERAPY. 2020 14 2194 38 THE EFFECTS OF YOGA VERSUS STRETCHING AND RESISTANCE TRAINING EXERCISES ON PSYCHOLOGICAL DISTRESS FOR PEOPLE WITH MILD-TO-MODERATE PARKINSON'S DISEASE: STUDY PRXOTOCOL FOR A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: PSYCHOLOGICAL DISTRESS IS PREVALENT AMONG PEOPLE WITH PARKINSON'S DISEASE (PD) AND AGGRAVATES THEIR MOTOR SYMPTOMS, THEREBY LEADING TO INCREASED DISABILITY, HIGH HEALTHCARE COSTS, AND POOR HEALTH-RELATED QUALITY OF LIFE (HRQOL). THE UNDER-RECOGNITION AND ADVERSE EFFECTS OF THE PHARMACOLOGICAL MANAGEMENT OF ANXIETY AND DEPRESSION AMONG THE PD POPULATION ARE CONSIDERABLE. THUS, ADOPTING A COMPLEMENTARY AND ALTERNATIVE MANAGEMENT (CAM) APPROACH TO ADDRESS THIS PROBLEM IS IMPORTANT. YOGA, ONE OF THE MOST COMMON "MIND-BODY" CAM THERAPIES, CAN IMPROVE THE PSYCHOLOGICAL WELLBEING OF PEOPLE WITH CHRONIC ILLNESSES. HOWEVER, LIMITED RESEARCH ON THE EFFECTS OF YOGA IN PEOPLE WITH PD HAS BEEN CONDUCTED. THIS STUDY WILL DETERMINE THE EFFECTS OF YOGA ON THE PSYCHOLOGICAL WELLBEING OF PEOPLE WITH MILD-TO-MODERATE PD AND WILL COMPARE THESE EFFECTS WITH THOSE OF STRETCHING AND RESISTANCE TRAINING EXERCISES. METHODS: A COMMUNITY-BASED, SINGLE-BLIND, RANDOMIZED TRIAL WILL BE CONDUCTED. A TOTAL OF 126 SUBJECTS WILL BE RECRUITED AND RANDOMLY DIVIDED INTO YOGA (N = 63) OR STRETCHING AND RESISTANCE EXERCISE (N = 63) GROUPS. FOR 8 WEEKS, THE YOGA GROUP WILL RECEIVE A WEEKLY 90-MIN SESSION OF YOGA, AND THE CONTROL GROUP WILL RECEIVE A WEEKLY 60-MIN SESSION OF STRETCHING AND RESISTANCE EXERCISES. THE PRIMARY OUTCOME WILL BE THE LEVEL OF PSYCHOLOGICAL DISTRESS MEASURED USING THE HOSPITAL ANXIETY AND DEPRESSION SCALE. THE SECONDARY OUTCOMES WILL INCLUDE THE SEVERITY OF MOTOR SYMPTOMS MEASURED BY THE MOVEMENT DISORDERS SOCIETY - UNIFIED PARKINSON'S DISEASE SCALE - PART III MOTOR EXAMINATION; MOBILITY, BALANCE, AND FALL RISK MEASURED BY THE TIMED UP AND GO TEST; SPIRITUAL WELLBEING MEASURED BY THE HOLISTIC WELLBEING SCALE; AND HRQOL MEASURED BY THE PARKINSON'S DISEASE QUESTIONNAIRE-8. ASSESSMENT WILL BE CONDUCTED AT BASELINE, 8TH, AND 20TH WEEKS OF FOLLOW-UPS. DISCUSSION: THIS STUDY WILL BE THE FIRST RANDOMIZED TRIAL TO COMPARE THE EFFECT OF YOGA VERSUS STRETCHING AND RESISTANCE TRAINING EXERCISES IN A PD POPULATION. RESULTS WILL CONTRIBUTE TO THE VALUE OF YOGA AS A THERAPEUTIC OPTION FOR MANAGING PSYCHOLOGICAL DISTRESS IN PD PATIENTS. MULTIPLE OUTCOMES INCLUDING PSYCHOLOGICAL, PHYSIOLOGICAL, AND SPIRITUAL AND HRQOL WILL ALSO BE MEASURED TO ELUCIDATE THE POTENTIAL MECHANISMS OF YOGA. THE EFFECT OF YOGA ON PEOPLE WITH CHRONIC ILLNESSES WILL FURTHER BE ELUCIDATED. THIS INFORMATION SHOULD CONTRIBUTE TO FUTURE RESEARCH, PRACTICE, AND POLICY RELATED TO PD MANAGEMENT. TRIAL REGISTRATION: WHO PRIMARY REGISTRY - CHINESE CLINICAL TRIALS REGISTRY (CHICTR): CUHK_CCRB00522 REGISTERED ON 8 OCTOBER 2016; DATE OF APPROVAL 19 AUGUST 2016. 2017 15 2300 32 THERAPEUTIC YOGA: SYMPTOM MANAGEMENT FOR MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS THE MOST COMMON AUTOIMMUNE INFLAMMATORY DEMYELINATING DISEASE OF THE CENTRAL NERVOUS SYSTEM, AFFECTING OVER 2.3 MILLION PEOPLE WORLDWIDE. ACCORDING TO THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, THE AGE OF DISEASE ONSET IS TYPICALLY BETWEEN 20 AND 40 YEARS, WITH A HIGHER INCIDENCE IN WOMEN. INDIVIDUALS WITH MS EXPERIENCE A WIDE RANGE OF SYMPTOMS, INCLUDING DECLINING PHYSICAL, EMOTIONAL, AND PSYCHOLOGICAL SYMPTOMS (E.G., FATIGUE, IMBALANCE, SPASTICITY, CHRONIC PAIN, COGNITIVE IMPAIRMENT, BLADDER AND BOWEL DYSFUNCTION, VISUAL AND SPEECH IMPAIRMENTS, DEPRESSION, SENSORY DISTURBANCE, AND MOBILITY IMPAIRMENT). TO DATE, BOTH THE CAUSE OF AND CURE FOR MS REMAIN UNKNOWN. IN RECENT YEARS, MORE INDIVIDUALS WITH MS HAVE BEEN PURSUING ALTERNATIVE METHODS OF TREATMENT TO MANAGE SYMPTOMS OF THE DISEASE, INCLUDING MIND-BODY THERAPIES SUCH AS YOGA, MEDITATION, BREATHING, AND RELAXATION TECHNIQUES. IT HAS BEEN SUGGESTED THAT THE PRACTICE OF YOGA MAY BE A SAFE AND EFFECTIVE WAY OF MANAGING SYMPTOMS OF MS. THEREFORE, THE PURPOSE OF THIS PAPER IS TO SUMMARIZE THE MOST RELEVANT LITERATURE ON EXERCISE AND MIND-BODY MODALITIES TO TREAT MS SYMPTOMS AND, MORE SPECIFICALLY, THE BENEFITS AND POTENTIAL ROLE OF YOGA AS AN ALTERNATIVE TREATMENT OF SYMPTOM MANAGEMENT FOR INDIVIDUALS WITH MS. THE ARTICLE ALSO DISCUSSES FUTURE DIRECTIONS FOR RESEARCH. 2015 16 2268 35 THE RATIONALE OF YOGA IN PARKINSON'S DISEASE: A CRITICAL REVIEW. BACKGROUND: PATIENTS WITH PARKINSON'S DISEASE (PD) COMMONLY USE COMPLEMENTARY AND ALTERNATIVE MEDICATIONS. YOGA IS A MIND-BODY INTERVENTION THAT IS BEING INCREASINGLY EXPLORED AS A TOOL IN THE THERAPEUTIC ARMAMENTARIUM OF PD. OBJECTIVE: TO CRITICALLY EVALUATE THE STUDIES AND SUMMARIZE THE UTILITY OF YOGA IN PD. MATERIAL AND METHODS: WE PERFORMED A SYSTEMATIC LITERATURE SEARCH IN THE MEDLINE AND COCHRANE DATABASES AND INCLUDED RANDOMIZED CONTROLLED TRIALS (RCT) OF YOGA IN PD. THE STUDIES WERE EVALUATED FOR INTERNAL VALIDITY AND THE RELEVANT DATA WERE EXTRACTED. RESULTS: A TOTAL OF SEVEN STUDIES WERE INCLUDED IN THE ANALYSIS. WE COLLATED THE DATA ON THE CHANGES IN MOTOR FUNCTION, GAIT AND BALANCE PARAMETERS, ANXIETY, DEPRESSION AND QUALITY OF LIFE SCORES OBSERVED AFTER INTERVENTION (YOGA) IN PATIENTS WITH PD AND HIGHLIGHTED THE LIMITATIONS OF THESE STUDIES. CONCLUSION: ANXIETY, DEPRESSION, AND BALANCE ISSUES IN PD MAY BENEFIT FROM YOGA. YOGA HAS POTENTIAL AS AN ADD-ON THERAPY IN PD. 2021 17 2490 30 YOGA AS AN INTERVENTION TO MANAGE MULTIPLE SCLEROSIS SYMPTOMS. MULTIPLE SCLEROSIS (MS) IS AN AUTOIMMUNE, DEMYELINATING, INFLAMMATORY DISEASE OF CENTRAL NERVOUS SYSTEM (CNS) WHICH IS CHARACTERIZED BY SPASTICITY, FATIGUE, DEPRESSION, ANXIETY, BOWEL AND BLADDER DYSFUNCTION, IMPAIRED MOBILITY, COGNITIVE IMPAIRMENT ETC. AND AFFECTS APPROXIMATELY 2.5 MILLION PEOPLE WORLDWIDE. DISEASE MODIFYING THERAPIES FOR MS WHICH HELP IN PREVENTING ACCUMULATION OF LESIONS IN WHITE MATTER OF CNS ARE COSTLY AND HAVE SIGNIFICANT ADVERSE EFFECTS. THEREFORE, PATIENTS WITH MS ARE USING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND YOGA IS ONE OF THE MOST POPULAR FORM OF CAM WHICH IS BEING USED IMMENSELY TO REDUCE OR OVERCOME THE SYMPTOMS OF MS. IN THE CURRENT REVIEW ATTEMPTED TO PRESENT THE POTENTIAL IMPACT OF YOGA PRACTICES ON REDUCING MS RELATED SYMPTOMS. 2020 18 2172 37 THE EFFECTS OF YOGA ON DEPRESSION AND MOTOR FUNCTION IN PATIENTS WITH PARKINSON'S DISEASE: A REVIEW OF CONTROLLED STUDIES. BACKGROUND: PARKINSON'S DISEASE (PD) IS A NEURODEGENERATIVE/NEUROPSYCHIATRIC DISORDER CHARACTERIZED BY BOTH MOTOR AND NON-MOTOR SYMPTOMOLOGY. THE REPORTED PREVALENCE OF DEPRESSION IN PATIENTS WITH PD IS DIFFICULT TO ASCERTAIN DUE TO OVERLAPPING SOMATIC SYMPTOMS AND FAILURE TO SELF-REPORT SYMPTOMS. ALTHOUGH ANTIDEPRESSANTS REMAIN A FIRST-LINE TREATMENT, THEY CAN HAVE ADVERSE EFFECTS. RECENTLY, LITERATURE HAS DEMONSTRATED THAT DUE TO ITS ANTI-INFLAMMATORY PROPERTIES, YOGA MAY BE AN EFFECTIVE NONPHARMACOLOGIC THERAPY FOR DEPRESSION. METHODS: A SEARCH WAS CONDUCTED TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) PUBLISHED FROM JANUARY 2000 TO JANUARY 2019 THAT ASSESSED THE EFFECTS OF YOGA ON DEPRESSION AND MOTOR FUNCTIONING IN PD. RESULTS: THREE STUDIES MET THE CRITERIA FOR INCLUSION. IN ONE RCT, BIWEEKLY YOGA RESULTED IN A DECREASE IN DEPRESSION SCORE (P = .056). IN ANOTHER RCT, WEEKLY YOGA RESULTED IN A SIGNIFICANT DECREASE IN DEPRESSION AND DEMONSTRATED THAT ITS THERAPEUTIC EFFECTS ARE LONG-LASTING. FINALLY, IN A THIRD RCT, NO SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN CONTROL AND EXPERIMENTAL GROUPS IN DEPRESSION AFTER BIWEEKLY YOGA. HOWEVER, YOGA WAS FOUND TO BE PROTECTIVE AGAINST WORSENING OF DEPRESSION. CONCLUSIONS: OUR REVIEW SUGGESTS THAT THE PRACTICE OF YOGA MAY BE A USEFUL NONPHARMACOLOGIC ADJUNCTIVE TREATMENT FOR DEPRESSION IN PATIENTS WITH PD. HOWEVER, MORE CONTROLLED RCTS ARE NEEDED TO VALIDATE OUR CONCLUSIONS. 2020 19 2369 32 WHAT ARE THE KNOWN EFFECTS OF YOGA ON THE BRAIN IN RELATION TO MOTOR PERFORMANCES, BODY AWARENESS AND PAIN? A NARRATIVE REVIEW. OBJECTIVE: THE CURRENT BODY OF LITERATURE WAS REVIEWED TO EVALUATE THE EFFECTS OF YOGA ON THE BRAIN IN RELATION TO MOTOR PERFORMANCE, BODY AWARENESS AND PAIN. BACKGROUND: YOGA HAS BEEN INCREASINGLY POPULAR IN THE WESTERN COUNTRIES ESPECIALLY FOR ITS UNIQUE INTEGRATION OF THE MIND AND BODY. YOGA HAS BEEN STUDIED MORE INTENSELY IN THE LAST DECADE. ALTHOUGH IT HAS BEEN SHOWN TO IMPROVE COGNITIVE FUNCTIONS, FEW STUDIES HAVE LOOKED INTO THE EFFECTS OF YOGA ON IMPROVING MOTOR PERFORMANCE, BODY AWARENESS OR PAIN AND THE POSSIBLE UNDERLYING BRAIN MECHANISMS ASSOCIATED WITH THEM. METHODS: A SEARCH OF THE CURRENT LITERATURE WAS MADE USING KEYWORDS SUCH AS: "YOGA BRAIN MOTOR", "YOGA BRAIN PAIN", "EFFECTS YOGA BRAIN" AND "EFFECTS YOGA BRAIN MOTOR PERFORMANCE". THE FINDINGS WERE THEN DISCUSSED IN RELATION TO MOTOR PERFORMANCE, BODY AWARENESS AND PAIN AND THEIR REPORTED MECHANISMS OF ACTION ON THE BRAIN. RESULTS: A TOTAL OF 61 ARTICLES WERE SELECTED, OUT OF WHICH 29 WERE EXCLUDED BECAUSE THEY DID NOT MEET OUR CRITERIA. A TOTAL OF THIRTY-TWO ARTICLES WERE INCLUDED IN THIS REVIEW, WHICH WE FURTHER SUBDIVIDED BY FOCUS: MOTOR PERFORMANCE (N=10), BODY AWARENESS (N=14) AND PAIN (N=8). DISCUSSION: OUR REVIEW SHOWS THAT YOGA HAS A POSITIVE EFFECT ON LEARNING RATE, SPEED AND ACCURACY OF A MOTOR TASK BY INCREASING ATTENTION AND DECREASING STRESS THROUGH A BETTER CONTROL OF SENSORIMOTOR RHYTHMS. YOGA ALSO SEEMS TO IMPROVE SENSORY AWARENESS AND INTEROCEPTION, REGULATE AUTONOMIC INPUT, INCREASE PARASYMPATHETIC ACTIVITY AND PROMOTE SELF-REGULATION. YOGA WAS ALSO SHOWN TO REDUCE THE THREAT SIGNAL, INCREASE PAIN TOLERANCE, DECREASE PAIN UNPLEASANTNESS AND DECREASE THE ANXIETY AND DISTRESS ASSOCIATED WITH PAIN. THOSE CHANGES ARE ASSOCIATED WITH THE RECRUITMENT OF SPECIFIC BRAIN AREAS SUCH AS THE INSULA, THE AMYGDALA AND THE HIPPOCAMPUS. CONCLUSION: BASED ON THE STUDIES REVIEWED IN THIS REPORT, WE FOUND THAT THE PRACTICE OF YOGA SEEMS TO FACILITATE MOTOR LEARNING, TO INCREASE BODY AWARENESS AND TO DECREASE PAIN. THESE ARE ASSOCIATED WITH A WIDE VARIETY OF CHANGES IN TERMS OF BRAIN ACTIVITY AND STRUCTURE. FURTHER STUDIES ARE NECESSARY TO REVEAL ITS PRECISE MECHANISM OF ACTION ON THE BRAIN AND TO VALIDATE ITS WIDER APPLICATION IN CLINICAL SETTINGS. 2019 20 1266 17 FLUID INTELLIGENCE AND BRAIN FUNCTIONAL ORGANIZATION IN AGING YOGA AND MEDITATION PRACTITIONERS. NUMEROUS STUDIES HAVE DOCUMENTED THE NORMAL AGE-RELATED DECLINE OF NEURAL STRUCTURE, FUNCTION, AND COGNITIVE PERFORMANCE. PRELIMINARY EVIDENCE SUGGESTS THAT MEDITATION MAY REDUCE DECLINE IN SPECIFIC COGNITIVE DOMAINS AND IN BRAIN STRUCTURE. HERE WE EXTENDED THIS RESEARCH BY INVESTIGATING THE RELATION BETWEEN AGE AND FLUID INTELLIGENCE AND RESTING STATE BRAIN FUNCTIONAL NETWORK ARCHITECTURE USING GRAPH THEORY, IN MIDDLE-AGED YOGA AND MEDITATION PRACTITIONERS, AND MATCHED CONTROLS. FLUID INTELLIGENCE DECLINED SLOWER IN YOGA PRACTITIONERS AND MEDITATORS COMBINED THAN IN CONTROLS. RESTING STATE FUNCTIONAL NETWORKS OF YOGA PRACTITIONERS AND MEDITATORS COMBINED WERE MORE INTEGRATED AND MORE RESILIENT TO DAMAGE THAN THOSE OF CONTROLS. FURTHERMORE, MINDFULNESS WAS POSITIVELY CORRELATED WITH FLUID INTELLIGENCE, RESILIENCE, AND GLOBAL NETWORK EFFICIENCY. THESE FINDINGS REVEAL THE POSSIBILITY TO INCREASE RESILIENCE AND TO SLOW THE DECLINE OF FLUID INTELLIGENCE AND BRAIN FUNCTIONAL ARCHITECTURE AND SUGGEST THAT MINDFULNESS PLAYS A MECHANISTIC ROLE IN THIS PRESERVATION. 2014